This Article Full Text Full Text (PDF) All Versions of this Article: 48/6/1020    most recent 01.HYP.0000248196.14826.31v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mogi, M. Articles by Horiuchi, M. Search for Related Content PubMed PubMed Citation Articles by Mogi, M. Articles by Horiuchi, M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Related Collections Lipids ACE/Angiotension receptors Developmental biology Lipid and lipoprotein metabolism Related Article

(Hypertension. 2006;48:1020.)
© 2006 American Heart Association, Inc.

Editorial Commentaries

Emerging Concept of Adipogenesis Regulation by the Renin–Angiotensin System

Masaki Mogi; Masaru Iwai; Masatsugu Horiuchi

From the Department of Molecular Cardiovascular Biology and Pharmacology, Ehime University, Graduate School of Medicine, Tohon, Ehime, Japan.

Correspondence to Masatsugu Horiuchi, Department of Molecular Cardiovascular Biology and Pharmacology, Ehime University, Graduate School of Medicine, Shitsukawa, Tohon, Ehime 791-0295, Japan. E-mail horiuchi@m.ehime-u.ac.jp

An extract of the first 250 words of the full text is provided, because this article has no abstract.

The renin–angiotensin system (RAS) has been the focus of attention not only for its classical action through circulating RAS but also its local actions in tissues such as the brain,¹ liver,² lung,³ and adipose tissue.⁴ The roles of the local RAS in adipose tissue have recently been highlighted, because obesity is one of the major risks for the metabolic syndrome with hypertension and glucose intolerance. However, there have been inconsistent reports on the role of the adipose tissue RAS. The role of local RAS in adipogenesis has been discussed but is not well elucidated.

In this issue of Hypertension, Matsushita et al⁵ examined the role of local RAS during adipocyte differentiation using human mesenchymal stem cells (MSCs) instead of preadipocytes in an elegant fashion. They reported the influence of RAS on MSCs as follows (Figure 1): (1) Comparison of the expression of RAS components between MSCs and differentiated adipocytes revealed that mRNA of renin and the angiotensin II (Ang II) type-2 (AT₂) receptor were highly expressed, and Ang II concentration was significantly increased in differentiated adipocytes; (2) administration of Ang II with or without an Ang II type-1 (AT₁) receptor blocker (ARB), valsartan, in MSC during adipogenesis showed that Ang II inhibited adipogenesis, and AT₂ receptor activation by valsartan further inhibited it; and (3) moreover, treatment with valsartan alone also inhibited adipocyte differentiation. These results suggest that the local RAS, especially AT₂ receptor signaling, has a crucial role in adipogenesis.

View larger version (41K):   Figure 1. Effect of endogenous . . . [Full Text of this Article]

Related Article:

Local Renin Angiotensin Expression Regulates Human Mesenchymal Stem Cell Differentiation to Adipocytes

Kenichi Matsushita, Yaojiong Wu, Yoshihisa Okamoto, Richard E. Pratt, and Victor J. Dzau
Hypertension 2006 48: 1095-1102. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

				J. D. Fowler, N. D. Johnson, T. A. Haroldson, J. A. Brintnall, J. E. Herrera, S. A. Katz, and D. A. Bernlohr Regulated renin release from 3T3-L1 adipocytes Am J Physiol Endocrinol Metab, June 1, 2009; 296(6): E1383 - E1391. [Abstract] [Full Text] [PDF]